trimethyloxamine has been researched along with eicosapentaenoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berge, RK; Bjørndal, B; Bohov, P; Bruheim, I; Nordrehaug, JE; Ramsvik, MS; Rostrup, E; Svardal, A | 1 |
| Chao, CY; Chiang, EI; Chiang, ER; Chiu, SC; Hung, HC; Rodriguez, RL; Syu, JN; Tang, FY; Wang, WJ | 1 |
1 trial(s) available for trimethyloxamine and eicosapentaenoic acid
| Article | Year |
|---|---|
Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study.
Topics: Adolescent; Adult; Animals; Atherosclerosis; Betaine; Carnitine; Choline; Chylomicrons; Cytokines; Dietary Fats, Unsaturated; Docosahexaenoic Acids; Eicosapentaenoic Acid; Erythrocytes; Euphausiacea; Fatty Acids, Unsaturated; Female; Humans; Lipoproteins, VLDL; Male; Methylamines; Particle Size; Pilot Projects; Triglycerides | 2015 |
1 other study(ies) available for trimethyloxamine and eicosapentaenoic acid
| Article | Year |
|---|---|
N-3 polyunsaturated fatty acids block the trimethylamine-N-oxide- ACE2- TMPRSS2 cascade to inhibit the infection of human endothelial progenitor cells by SARS-CoV-2.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Docosahexaenoic Acids; Eicosapentaenoic Acid; Endothelial Progenitor Cells; Fatty Acids, Omega-3; Humans; Interleukin-6; Methylamines; MicroRNAs; NF-kappa B; Oxides; Peptidyl-Dipeptidase A; SARS-CoV-2; Serine Endopeptidases | 2022 |